restless legs syndrome rls also known disease wed generally longterm disorder causes strong urge move ones often unpleasant feeling legs improves somewhat moving often described aching tingling crawling occasionally arms may also feelings generally happen rest therefore make hard due disturbance sleep people rls may sleepy day low energy feel irritable additionally many limb twitching sleep condition known periodic limb movement rls habitual foottapping risk factors rls include low iron levels kidney failure parkinsons disease diabetes mellitus rheumatoid arthritis pregnancy celiac number medications may also trigger disorder including antidepressants antipsychotics antihistamines calcium channel restless leg syndrome may either earlyonset occurring age lateonset occurring age earlyonset cases tend progress slowly involve fewer comorbidities cases older patients may progress suddenly alongside diagnosis generally based persons symptoms ruling potential restless legs syndrome may resolve underlying problem otherwise treatment includes lifestyle changes lifestyle changes may help include stopping alcohol tobacco use sleep medications used treat rls include dopamine agonists like pramipexole gabapentinoids ligands like rls affects estimated american females commonly affected males becomes increasingly common sir thomas willis provided medical description willis emphasized sleep disruption limb movements experienced people rls subsequently descriptions rls published including theodor wittmaack de relation sometimes known wittmaackekbom karlaxel ekbom provided detailed comprehensive report condition doctoral thesis restless legs clinical study hitherto overlooked ekbom coined term restless legs ekboms work largely ignored rediscovered arthur walters wayne hening subsequent landmark publications include papers revised updated diagnostic rls sensations range pain aching muscles itch cant scratch buzzing sensation unpleasant tickle wont stop crawling feeling limbs jerking awake sensations typically begin intensify quiet wakefulness relaxing reading studying trying spectrum disorder people experiencing minor annoyance others major disruption sleep impairments quality need return immediately ceasing movement later time rls may start age including childhood progressive disease symptoms may remit survey among members restless legs syndrome foundation found patients first symptoms age rls may contribute higher rates depression anxiety disorders rls rls categorized either primary secondary cause generally unknown believed caused changes neurotransmitter resulting abnormal use iron rls often due iron deficiency low total body iron could sign anemia caused internal bleeding bone marrow issues associated conditions may include endstage kidney disease hemodialysis folate deficiency magnesium deficiency sleep apnea diabetes peripheral neuropathy parkinsons disease certain autoimmune diseases multiple rls worsen pregnancy possibly due elevated estrogen use alcohol nicotine products caffeine may associated study american academy neurology also found reduced leg oxygen levels strongly associated restless legs syndrome symptom severity untreated association observed attention deficit hyperactivity disorder adhd rls periodic limb movement conditions appear links dysfunctions related neurotransmitter dopamine common medications conditions among systems affect dopamine levels study suggested people adhd comorbid ie coexisting rls people rls confirmed adhd symptoms certain medications may cause worsen rls cause secondarily primary secondary rls worsened surgery kind however back surgery injury associated causing cause vs effect certain conditions behaviors observed patients ex excess weight lack exercise depression mental illnesses well established loss sleep due rls could cause conditions medication used treat condition could cause cases rls familial inherited autosomal dominant fashion variable research brain autopsies implicated dopaminergic system iron insufficiency substantia iron well understood essential cofactor formation ldopa precursor dopamine six genetic loci found linkage known listed first one linkage loci discovered using autosomal dominant model inheritance three genes found associated role rls pathogenesis still unclear recently fourth gene ptprd found associated also evidence periodic limb movements sleep plms associated chromosome presence positive family history suggests may genetic involvement etiology rls although partly understood pathophysiology restless legs syndrome may involve dopamine iron system also commonly acknowledged circadian rhythm explanatory mechanism associated clinically shown simply biomarkers circadian rhythm body interactions impaired neuronal iron uptake functions neuromelanincontaining dopamineproducing cells roles rls development indicating iron deficiency might affect brain dopaminergic transmissions different medial thalamic nuclei may also role rls part limbic system modulated dopaminergic may affect pain improvement rls symptoms occurs people receiving lowdose dopamine specific tests rls nonspecific laboratory tests used rule causes vitamin deficiencies five symptoms used confirm symptoms essential like ones occur commonly rls according international classification sleep disorders main symptoms associated sleep disturbance impairment order support rls stated classification rls symptoms begin worsen inactive relieved moving happen exclusively mostly evening night triggered medical behavioral conditions impair ones quality generally legs affected cases asymmetry common conditions differentiated rls include leg cramps positional discomfort local leg injury arthritis leg edema venous stasis peripheral neuropathy radiculopathy habitual foot tappingleg rocking anxiety myalgia druginduced peripheral artery disease arthritis also cause leg pain usually gets worse less common differential diagnostic conditions included myelopathy myopathy vascular neurogenic claudication hypotensive akathisia orthostatic tremor painful legs moving rls linked underlying cause frequency may reduced lifestyle modifications adopting improving sleep hygiene regular exercise stopping medications used may include dopamine agonists gabapentinoids daily restless legs severe refractory cases opioids treatment rls considered possible medical causes ruled secondary rls may cured precipitating medical conditions anemia managed stretching leg muscles bring temporary walking moving legs name restless legs implies brings temporary relief fact rls often almost uncontrollable need walk therefore relieve symptoms moving unfortunately symptoms usually return immediately moving walking ceases counterstimulation massage hot cold compress vibratory counterstimulation device found help people primary rls improve evidence intravenous iron supplementation moderately improves restlessness people whose rls disrupts prevents sleep regular daily activities medication may useful evidence supports use dopamine agonists including pramipexole ropinirole rotigotine cabergoline reduce symptoms improve sleep quality quality levodopa also however pergolide cabergoline less recommended due association increased risk valvular heart ropinirole faster onset shorter rotigotine commonly used transdermal patch continuously provides stable plasma drug concentrations resulting particular therapeutic effect patients symptoms throughout metaanalysisneeds update found pramipexole better however issues use dopamine agonists including augmentation medical condition drug causes symptoms increase severity andor occur earlier day dopamine agonists may also cause rebound symptoms increase drug wears many cases longer dopamine agonists used higher risk augmentation rebound well severity symptoms patients may also develop dopamine dysregulation syndrome meaning experience addictive pattern dopamine replacement therapy study indicated dopamine agonists used restless legs syndrome lead increase compulsive patients may also exhibit impulsecontrol disorders compulsive shopping compulsive indications stopping dopamine agonist treatment impact resolution least improvement impulsecontrol disorder even though people particularly exposed dopamine agonist withdrawal gabapentinoids ligands including gabapentin pregabalin gabapentin enacarbil also widely used treatment used firstline treatments similarly dopamine agonists guidelines started recommend gabapentinoids dopamine agonists initial therapy rls due higher known risks symptom augmentation longterm dopamine agonist gabapentin enacarbil approved regulatory authorities treatment rls whereas gabapentin pregabalin used data gabapentinoids treatment rls limited compared dopamine however based available evidence gabapentinoids similarly effective dopamine agonists treatment low doses opioids used treatment severe treatmentresistant cases recommended multiple reputable medical commonly used agents prolongedrelease oxycodone methadone opioids including tramadol codeine morphine hydrocodone may also opioids indicated severe cases respond measures due high abuse liability high rate side effects may include constipation fatigue however opioids said highly effective severe refractory rls helpful wellselected benzodiazepines diazepam clonazepam generally effectiveness unknown however sometimes still used secondline addon treatments also explored valproate carbamazepine perampanel dipyridamole either effective insufficient data support placebos provide large benefit terms reduction rls thought due positive expectancy effects conditioning activate dopamine opioid pathways dopamine agonists opioids used effective treatment rls thought related effectiveness placebos half benefit rls medications pramipexole gabapentin enacarbil appears due placebo component based clinical trial rls symptoms may gradually worsen age although slowly idiopathic form rls people also associated medical current therapies control disorder minimizing symptoms increasing periods restful sleep addition people remissions periods symptoms decrease disappear days weeks months although symptoms usually eventually diagnosed rls indicate foreshadow another neurological disease parkinsons rls symptoms worsen time dopaminerelated drugs used therapy effect called augmentation may represent symptoms occurring throughout day affect movements cure rls affects estimated american minority around population experience daily severe rls twice common women caucasians prone rls people african rls occurs individuals mediterranean middle eastern regions east asia indicating different genetic environmental factors including diet may play role prevalence rls diagnosed older age runs severe rls even common individuals iron deficiency pregnancy endstage kidney national sleep foundations sleep america poll showed percent pregnant women developed rls third poor general health also several risk factors rls including old age family history uremia prevalence rls tends increase age well severity longer duration symptoms people uremia receiving renal dialysis prevalence kidney transplant improve compared treated rls occur ages although typically begins third fourth association studies identified risk loci associated neurological conditions linked rls include parkinsons disease spinal cerebellar atrophy spinal stenosisspecify lumbosacral radiculopathy disease type restless legs syndrome foundation renamed disease foundation however reverted original name better support mission point confusion rls delusional parasitosis entirely different conditions called ekbom syndrome syndromes described person karlaxel today calling wedrls ekbom syndrome outdated usage unambiguous names wed rls preferred clarity doctors express view incidence restless legs syndrome exaggerated manufacturers drugs used treat others believe underrecognized undertreated glaxosmithkline gsk ran advertisements promoting offlicence use drug ropinirole treatment rls link ekbom support group website website contained statements advocating use ropinirole treat rls association british pharmaceutical industry abpi ruled gsk different measurements used evaluate treatments rls based subjective rating scores irls rating scale irls clinical global impression cgi patient global impression pgi quality life questionnaires provide information severity progress disease well persons quality life polysomnography psg actigraphy related sleep parameters objective resources provide evidences sleep disturbances associated rls disease httpsenwikipediaorgwikirestlesslegssyndrome